IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare autoimmune disease
Disease control CompletedThis study tested a new drug called rilzabrutinib, taken with steroids, to see if it can better control IgG4-related disease (a rare condition where the immune system attacks the body). 27 adults with active disease were enrolled. The goal was to reduce disease flares and side ef…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New drug shrinks swollen glands in rare autoimmune disease
Disease control CompletedThis study tested a drug called zanubrutinib in 10 adults with IgG4-related disease, a condition that causes swelling in glands and other organs. The goal was to see if the drug could safely reduce gland size and inflammation. Results suggest it may help control the disease, but …
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Matthew C. Baker • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC
-
Scientists probe immune cell clues in rare IgG4 disease
Knowledge-focused CompletedThis study looked at a rare disease called IgG4-related disease, which can damage organs. Researchers measured special immune cells (follicular helper T cells) in the blood of 75 people: patients with the disease, patients with Sjogren syndrome, and healthy volunteers. The goal w…
Matched conditions: IGG4 RELATED DISEASE
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC